This peptide continues to be going through medical investigation, and researchers are most likely still refining the exceptional dosage for their studies as a consequence of its novelty. Retatrutide is the newest fat loss medication that acts as a triple agonist at GLP-one, GIP, and glucagon receptors. The medication is indicated for weightloss,